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LiverLipids are essential for cellular function as sources of fuel, critical signaling molecules and membrane compo-
nents. Deﬁciencies in lipid processing and transport underlie many metabolic diseases. To better understand
metabolic function as it relates to disease etiology, a whole animal approach is advantageous, one in which
multiple organs and cell types can be assessed simultaneously in vivo. Towards this end, we have developed
an assay to visualize fatty acid (FA) metabolism in larval zebraﬁsh (Danio rerio). The method utilizes egg yolk
liposomes to deliver different chain length FA analogs (BODIPY-FL) to six day-old larvae. Following liposome
incubation, larvae accumulate the analogs throughout their digestive organs, providing a comprehensive
readout of organ structure and physiology. Using this assay we have observed that different chain length
FAs are differentially transported and metabolized by the larval digestive system. We show that this assay
can also reveal structural and metabolic defects in digestive mutants. Because this labeling technique can
be used to investigate digestive organ morphology and function, we foresee its application in diverse studies
of organ development and physiology.farber@ciwemb.edu
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To understand complex physiological events there is a pressing need
to overlay metabolic information onto well-characterized cellular pro-
cesses (McKnight, 2010). Across diverse ﬁelds, biologists routinely
identify and characterize mutants using morphological criteria to un-
cover mechanisms underlying cellular phenomena (Morgan, 1932;
Nusslein-Volhard, 1994). Techniques such as immunohistochemistry,
in situ hybridization, and electron microscopy are utilized to visualize
cellular and subcellular structure; however, these methods do not
always reveal the physiological consequences of a mutation or given
experimental perturbation. Furthermore, mutants lacking overt mor-
phological abnormalities may have deﬁciencies in other respects (e.g.,
behavioral or metabolic). Thus, physiological assays should also be
used to screen for and functionally characterize mutants to provide a
more complete understanding of gene function.
Fluorescent lipid analogs offer a way to assess both the morpholo-
gy and metabolic function of digestive organs and lipid storing tissues
(Farber et al., 2001). Many of the properties that make imaging lipids
at the subcellular level difﬁcult, such as their small size, dynamic sub-
cellular behavior, and propensity to be metabolized into different spe-
cies, enable lipid analogs to provide a wealth of information about a
mutation's physiological impact. Advancements in lipid analogs and
live-imaging techniques have improved the imaging of lipids at thesubcellular level (Schultz et al., 2010), yet cultured cells remain the pre-
dominant models of choice (Guo et al., 2008; Spandl et al., 2009). To
image lipid metabolism in an intact vertebrate digestive system, we
have developed a feeding assay to visualize FA uptake, accumulation,
and transport in live zebraﬁsh larvae. Zebraﬁsh possess many of the
same digestive organs, cells, and genes as humans do (Andre et al.,
2000; Marza et al., 2005; Schlegel and Stainier, 2006; Wallace and
Pack, 2003; Wallace et al., 2005), and are currently being used as
models of metabolic disorders such as diet-induced obesity (Oka et al.,
2010), atherosclerosis (Stoletov et al., 2009), and diabetes (Elo et al.,
2007). At the onset of exogenous feeding at approximately 5 days post-
fertilization (dpf), zebraﬁsh larvae possess a functional digestive system
and remain largely transparent, allowing them to be utilized for studies
of digestive physiology in vivo (Farber et al., 2001).
The dietary fat consumed by humans and zebraﬁsh alike consists pri-
marily of triacylglycerol (TAG), which must be processed by digestive
enzymes and bile for intestinal absorption (Benzonana and Desnuelle,
1965; Black, 2007; Sarda and Desnuelle, 1958; Young and Hui, 1999).
Pancreatic acinar cells produce, package, and secrete digestive enzymes
into the pancreatic ducts by fusion of zymogen granules with the apical
acinar cell membrane (reviewed by Lowe, 2002). After draining into
the common bile duct, pancreatic lipases mix with bile derived from
the liver. Hepatocytes drain bile into ‘little canals’ termed canaliculi,
which direct bile into hepatic ducts that empty into the gall bladder
(Lorent et al., 2004; Pack et al., 1996). In response to stimulation by
the hormone cholecystokinin (CCK), bile and fat-splitting enzymes in
the gall bladder are pumped into the intestinal lumen to emulsify TAG
by forming mixed micelles (reviewed by Iqbal and Hussain, 2009).
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cells of the intestine (Thomson et al., 1993).
Following intestinal absorption and conversion of FAs into acyl-CoA
by acyl-CoA synthetases (Lehner and Kuksis, 1995; Manganaro and
Kuksis, 1985a; Manganaro and Kuksis, 1985b), activated FAs have a
number of potential metabolic fates including being burned to generate
acetyl-CoA via alpha or beta-oxidation, synthesized into neutral lipids
and stored in cytoplasmic lipid drops (Fig. 1B), or used for membrane
phospholipid synthesis (Ellis et al., 2010). Neutral lipids destined for de-
livery to other tissues and organs in the body are secreted as intestinal
lipoproteins, termed chylomicrons, from the basolateral surface of
enterocytes (Fig. 1B). Following secretion, these lipoproteins travel to
the liver where they bind lipoprotein receptors that are internalized
and subsequently metabolized (Bloom et al., 1950; McDonald et al.,
1980; Vallot et al., 1985).
In an attempt to visualize these steps of dietary FAmetabolism in the
digestive system of larval zebraﬁsh, we selected BODIPY-FL analogs
(Invitrogen, Inc), which have been used to visualize lipid droplets inBODIP
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Fig. 1. BODIPY-FL C16 accumulates in lipid droplets in the digestive organs of live larval zebraﬁs
intestinal bulb readily absorb BODIPY-FL C16 following an egg yolk and analog feed. The dotted b
of BODIPY-FL C16. Larger gaps in intestinal ﬂuorescence (arrow) are likely non-absorbing enter
testinal enterocytes. Enterocytes take up lipids from the intestinal lumen, form lipid droplets (l
cleus (n) are also indicated. C. Intestinal enterocytes (dotted box indicates a single enterocyte) o
foci reminiscent of chylomicrons. The intestinal lumen is indicated (asterisk). D. BODIPY-FL C1
ducts (arrow). Hepatocyte nuclei (empty arrowhead) are also visible. E. BODIPY-FL C16 accum
neath the exocrine pancreas, an intestinal blood vessel (arrow) running the length of the intest
arate confocal images. Scale bars=10μm. (n=3; 6 larvae per feed.)cultured cells (Huang et al., 2004; Karsenty et al., 2009) and whole or-
ganisms (Furlong et al., 1995; Mak et al., 2006; Zhang et al., 2010).
These analogs consist of a BODIPY-tagged saturated acyl chain of varying
lengths. Saturated FAs are classiﬁed by their chain length (short: 2–6
carbons, medium: 8–12 carbons, long: 14–20, and very long: ≥22)
(reviewed by Papamandjaris et al., 1998). The BODIPY ﬂuorophore itself
(4,4-diﬂuoro-4-bora-3a, 4a-diaza-S-indacene) possesses several charac-
teristics that make it useful for imaging lipids, including high photo-
stability, a strong and narrow wavelength emission in the visible
spectrum, and an overall uncharged state (Treibs and Kreuzer, 1969).
Using these ﬂuorescent FAs we have conducted a comparative
study of short, medium, and long chain FA (LCFA) BODIPY analogs.
We have found that larval ingestion of different chain length analogs
results in unique patterns of FA localization across multiple organs
and cell types including intestinal enterocytes, hepatocytes, and pan-
creatic acinar cells. TLC analysis of total larval lipids conﬁrms that the FA
analogs are metabolized, with the metabolic proﬁle of each analog con-
sistentwith its in vivo localization pattern. Furthermore,we have utilizedY-FL C16
C
*
h. In all images, anterior is to the right to allow liver viewing. A. Enterocytes of the anterior
ox indicates a row of intestinal enterocytes exhibiting apical and basolateral accumulation
oendocrine cells (Wallace et al., 2005). B. A schematic of lipid metabolism in polarized in-
d) and secrete basolateral chylomicrons (cm). The basement membrane (bm) and cell nu-
f larvae fed BODIPY-FL C16 display apical lipid droplets and smaller basolateral ﬂuorescent
6 accumulates within large hepatic lipid droplets (ﬁlled arrowhead) and faintly in hepatic
ulates throughout the exocrine pancreas, forming small ﬂuorescent foci (arrowhead). Be-
ine ﬂuoresces, indicating analog entry into the vascular system. A is a composite of 3 sep-
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mutant, fat-free. Analog feeding conﬁrms the morphological defects pre-
viously identiﬁed in this mutant and reveals a bile secretion defect, fur-
ther implicating Fat-free in secretory vesicle trafﬁcking (Ho et al., 2006).
Materials and methods
Zebraﬁsh strains and ﬁsh maintenance
All experiments were carried out using zebraﬁsh larvae (AB
strain) at 6 dpf. Thin layer Chromatography (TLC) analysis was per-
formed using Farber wildtype (FWT) larvae (6 dpf). The FWT line
was created to increase the fecundity of the AB stock and is the product
of an AB line outcrossed to a pet store line, which was then inbred over
several generations. Larvaeweremaintained in accordancewith the Car-
negie Institution's Animal Care and Use Committee Protocol (#139). Ho-
mozygous mutant fat-free larvae were identiﬁed phenotypically using a
previously described hypopigmentation assay (Ho et al., 2006) and de-
ﬂated swim bladders (Farber et al., 2001).
Fluorescent analogs
All BODIPY analogs used in this study were obtained from Invitrogen
and stored at stock concentrations in chloroformat−80 °C. The following
green ﬂuorescent BODIPY analogs were used to visualize FA metabolism
in larval zebraﬁsh: BODIPY-FL C16 (D-3821), BODIPY-FL C12 (D-3822),
BODIPY-FL C5 (D-3834), BODIPY-FL C2 (D-2183), and BODIPY 493/503
(D-3922). For all feedings, the BODIPY analogs were evaporated under
a stream of Nitrogen gas and resuspended in 200 proof ethanol (5–
10 μL) in Eppendorf tubes. Zebraﬁsh embryo medium (EM; 90–95 μL)
was added to the resuspended solution. The resulting ﬂuorescent
stock solutions were protected from light with aluminum foil, as were
the larvae during feeding in plastic 6-well culture plates. The BODIPY
ﬂuorophore is 2–3 carbon lengths long, effectively making the analogs
longer than their chain length designation. Additionally, high concen-
trations of the green BODIPY ﬂuorophore can self-quench or red shift
due to excimer formation and this should be considered if cofeeding an-
alogs that emit in the red spectr or when using transgenic larvae
(Pagano et al., 1991).
Preparation and feeding of ﬂuorescent liposomes
To make the ﬂuorescentum vesicle feeding solution, a 5% egg yolk
emulsion was prepared with zebraﬁsh EM. 1 mL of frozen chicken egg
yolk (Land O’ Lakes brand eggs) was thawed to room temperature
and mixed with zebraﬁsh EM (19 mL). The resulting mixture was
pulse sonicated with a 1/4th inch tapered microtip (5 s total proces-
sing time, 1 s on, 1 s off, output intensity: 3 W) continuously for
2 min (Sonicator Ultrasonic Processor 6000, Misonix Inc., Farmingdale,
New York, USA). The resuspended BODIPY analog was quickly added
to 5 mL of the emulsion and vortexed for 30 s for a ﬁnal concentration
of 6.4 μM BODIPY-FL. Vesicle formation was conﬁrmed by viewing 10–
20 μL of the solution between coverslips using confocal microscopy
(Fig. S1 in supplementary material). For administering BODIPY-FL ana-
logs in the absence of egg yolk, the resuspended analogs were added to
1 mL of 5% FA-free bovine serum albumin (BSA; cat. # A8806-5G,
Sigma) and pipetted several times to mix well. To this solution, 4 mL
of zebraﬁsh EM was added and mixed well. Before liposome feeding,
larvae were screened for signs of developmental delay (e.g., unabsorbed
yolk, deﬂated swim bladder, malformed jaw) or abnormal digestive
organ morphology. Twenty larvae were placed in 5 mL of the ﬂuores-
cent vesicle solution and fed in a 6-well culture dish on a slowlymoving
orbital shaker for 4–8 h.We did not detect any obvious signs of toxicity
during feeding. After feeding, larvae were washed several times in EM
to remove residual label, anesthetized with MESAB, and live mountedfor imaging in a small volume of 3% methylcellulose solution under a
coverslip.
Microscopy
Imaging was performed using an SP2 confocal microscope (Leica
Microsystems, Deerﬁeld, Illinois, USA) with an Argon laser under a
63× oil objective. To image FA accumulation inmultiple digestive organs
it was often necessary to merge several single images together.
Synthesis of BODIPY standards
In addition to the BODIPY-FL analogs, the following BODIPY-
tagged lipids (Invitrogen, Inc.) were used as TLC standards: three
BODIPY-phosphatidylcholines (a- BODIPY 530/550-C5-HPC (D3815);
a- BODIPY 530/550-C12-HPC, (D3792); and a- BODIPY 530/550-C16-
HPC (D7707 discontinued)) and BODIPY-cholesteryl (cholestryl- BOD-
IPY-FL C12, (C3927MP)). BODIPY-tagged triacylglyceride (BODIPY-
TAG) and diacylglyceride (BODIPY-DAG) standards are not commer-
cially available at the time and were synthesized in vitro.
To synthesize BODIPY-DAG standards of different chain lengths,
we utilized phospholipase C (PLC, P-9439, Sigma) to enzymatically
cleave the phosphatidylcholine moieties from BODIPY-C16-HPC,
BODIPY-C12-HPC, and BODIPY-C5-HPC analogs (Farber et al., 1999).
PLC was dissolved in 20 mM Tris, 10 mM CaCl2, pH 7.5 at a stock con-
centration of approximately 1 Unit/μL. To synthesize BODIPY-DAG,
approximately 50 μg of the desired BODIPY-PC (either -C5, -C12, or
-C16) was dried down with nitrogen gas and resuspended in ethanol
(10 μL, 200 proof). PLC enzyme (20 Units) and EM (80 μL) were added
to the BODIPY-PC substrate solution, mixed well, and incubated at
37 °C for 5 h. All DAG synthesis reactions were stopped by chloroform:
methanol:water (2:1:1 v/v) extraction. The resulting organic phase was
dried down with nitrogen gas, resuspended in ethanol (20 μL), and
stored at −20 °C. Reaction efﬁciency was assayed using TLC and an
ethyl ether/benzene/ethanol solvent system (8:13.5:0.5 v/v). TLC analy-
sis revealed that generation of BODIPY-DAGby PLC-mediated cleavage of
BODIPY-PC proceeded nearly to completion, with very little remaining
substrate detected (data not shown).
To generate BODIPY-TAG from newly synthesized BODIPY-DAG, we
generated mouse liver microsomes containing the TAG-synthesizing
enzyme acyl CoA diacylglycerol transferase (Dgat) (Yu et al., 2010).
Brieﬂy, liver tissue (0.2 g) from a fasted mouse (Black 6 strain) was ho-
mogenized in ice-cold buffer (100 mM sucrose, 50 mMpotassium chlo-
ride, 30 mM EDTA, 40 mM monopotassium phosphate, pH 7.2) and
centrifuged (10,000×g in a Beckman L8-M Ultracentrifuge, SW41
rotor) for 15 min at 4 °C. To pellet Dgat-containing microspheres, the
supernatant was collected and recentrifuged (100,000×g in an Optima
TLXUltracentrifuge) for 70 min. Themicrosphereswere aliquoted,ﬂash
frozen in liquid nitrogen, and stored at−80 °C. The TAG synthesis reac-
tion was prepared by ﬁrst drying down the volume equivalent of 40 μg
of BODIPY-DAG with nitrogen gas. Acetone (10 μL) and reaction buffer
(312 μL of 100 mM Tris–HCl, pH 7.5, 150 mM magnesium chloride,
1.25 mg/mL FA-free BSA, 200 mM sucrose, 1 mM EDTA) were added.
The mixture was pulse sonicated (6×3 second pulses, output intensity
2 W). Palmitoyl Coenzyme A (4 μL of a 1 mM stock) and liver micro-
somes (10 μg) were added to the reaction mixture and incubated at
37 °C for 2 h. Total lipids were extracted and separated by TLC as de-
scribed. Although TLC analysis revealed BODIPY-TAG synthesis to be
relatively inefﬁcient (data not shown), a sufﬁcient amount of BODIPY-
TAG was produced for use as a TLC standard.
Fluorescent thin layer chromatography
To determine if BODIPY-FL analogs are metabolized by zebraﬁsh
larvae, TLC analysis was performed on larval lipid extracts. Lipids
were extracted from 60 larvae that had been fed BODIPY-FL C16,
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Following a 4–8 h incubation in liposomes, larvae were washed sev-
eral times with EM to remove trace amounts of the feeding solution,
pelleted on ice, and pulse sonicated in 500 μL of cold (4 °C) EM.
Total lipids were extracted from larval homogenates, as described
above. The organic phase was collected and stored at −80 °C in
brown glass vials (National Scientiﬁc, Rockwood, Tennessee, USA)
until TLC analyses were performed.
A two-solvent system was used to resolve BODIPY meta-
bolites present in extracted samples. The ﬁrst polar solvent system
(chloroform/ethanol/triethylamine/water (30:34:30:8 mL) sepa-
rated phospholipids and BODIPY-FL. The second solvent system
(petroleum ether/ethyl ether/acetic acid) (45:5:0.5 mL) resolved
TAG from cholesterol ester (CE) and BODIPY493/503. Solvent sys-
tems were added to TLC chambers and allowed to equilibrate for
at least 20 min prior to sample separation. Samples and BODIPY
standards were spotted onto silica gel TLC plates (Whatman,
LK5D; EMD Biochemicals) and dried for several minutes. Following
tank equilibration, plates containing the samples were run until the sol-
vent front reached 1 cm from the top of the plate. After drying, plates
were scanned (Storm Scanner 860; Molecular Dynamics, USA) using
the blue ﬂuorescence laser (excitation: 450 nm; emission: 520LP; PMT
800 V, 200 m pixel size) to detect ﬂuorescent bands.
Results and discussion
In this studywe selected four BODIPY-tagged FA analogs to adminis-
ter to zebraﬁsh larvae: the short chain acetic acid (BODIPY-FL C2), the
medium chains pentanoic (BODIPY-FL C5) and lauric acid (BODIPY-FL
C12), and the long chain palmitic acid (BODIPY-FL C16). We also admin-
istered the nonmetabolizable BODIPY ﬂuorophore (BODIPY 493/503) to
determine to what degree the ﬂuorophore alone could visualize FA
metabolism.
To deliver BODIPY-FL analogs to larval zebraﬁsh, we simulated a
high-fat diet by administering the analogs in chicken egg yolk lipo-
somes. Previous studies in adult (Marza et al., 2005) and larval (Walters
et al. submitted) zebraﬁsh have reported the increased appearance of
intestinal lipid droplets and the upregulation of FA metabolism genes
following an egg yolk meal. Liposomes were made by sonicating chick-
en egg yolk to disperse yolk lipid aggregates, which reform into small,
more homogeneous vesicles (Finer et al., 1972).
BODIPY-FL analogs partition into different liposomal compartments
Following addition to sonicated egg yolk, BODIPY-FL analogs par-
tition into distinct liposomal compartments (Fig S1). BODIPY-FL C16
liposomes appear as rings in confocal images, indicating analog parti-
tioning into the liposomal membrane. BODIPY-FL C12, C5, and C2 par-
tition into the aqueous core of liposomes, which appear as ﬂuorescent
ovals in confocal images (Fig S1). BODIPY 493/503 also partitions into
the liposome interior.
The BODIPY ﬂuorophore does not recapitulate fatty acid metabolism in
larval zebraﬁsh
When administered to zebraﬁsh larvae, the BODIPY ﬂuorophore
ﬁrst accumulates in intestinal lipid droplets in the anterior intestine,
then gradually accumulates in the hepatic ducts over time (Fig. S2).
Previous studies in medaka (Oryzias latipes) have shown that this
ﬂuorophore accumulates in the gall bladders, intrahepatic biliary sys-
tems, and intestines of larvae soaked in the ﬂuorophore at the early
morula stage (Hornung et al., 2004). The apparent exclusion of BODIPY
from hepatic lipid droplets suggests that the ﬂuorophore's lack of an
acyl chain hinders its hepatic uptake. Interestingly, the ﬂuorophore it-
self readily enters intestinal lipid drops, suggesting differential FA im-
port mechanisms in the intestine and liver.BODIPY-FL analog feeding visualizes FA metabolism in zebraﬁsh larvae
To better visualize FA metabolism, we selected four different chain
length BODIPY FA analogs to administer to zebraﬁsh larvae.We reasoned
that ﬂuorescent analogs that mimicked short, medium, and long chain
saturated FAswould bemetabolized similarly to their native counterparts
and more faithfully recapitulate FA metabolism. Saturated BODIPY-FL
analogs are poorly metabolized by cultured cells (Huang et al., 2004;
Thumser and Storch, 2007), prompting some to utilize BODIPY-FL as
nonmetabolizable analogs (Atshaves et al., 2004; Huang et al., 2004);
however, BODIPY-FL C12 has been shown to bemetabolized by the par-
asitic worm Schistosoma mansoni (Furlong et al., 1995), suggesting
endogenous factors absent in cultured cell models (e.g., bile, gut mi-
crobes) are necessary for appreciable BODIPY-FL metabolism.
When administered to zebraﬁsh larvae, long, medium, and short
chain BODIPY-FL analogs accumulate in distinct subcellular patterns
in larval digestive organs (Figs. 1–4). Following a liposome feed, ana-
logs appear sequentially in the digestive organs of larvae, accumulat-
ing in the intestine ﬁrst (1–2 h feed), then the liver (2–4 h feed), and
ﬁnally in the pancreas (4–6 h feed).
BODIPY-FL C16
BODIPY-FL C16 appears throughout the intestine of larval zebraﬁsh
(Fig. 1), accumulating in apical and basolateral domains of intestinal
enterocytes (Fig. 1A). Fluorescent lipid droplets form in the lumenal
side of enterocytes, while small, ﬂuorescent foci appear in the basolateral
region (Fig. 1C), revealing these cells to be functionally polarized. The po-
larity of BODIPY-C16 accumulation in intestinal enterocytes is highly
reminiscent of the apical lipid droplets and basolateral chylomicrons
seen in electron micrographs of larval zebraﬁsh enterocytes fed a high-
fat diet (Walters et al., submitted). This functional polarity also coincides
with the previously characterized appearance of apical and basolateral
speciﬁc proteins in enterocytes, including the apical tight junction
marker ZO-1 and the basolateral transporter sodium potassium ATPase
(Wallace and Pack, 2003; Wallace et al., 2005). In addition, ﬂuorescent
lipid droplets appear in the livers and exocrine pancreases of BODIPY-
C16 fed larvae (Fig. 1D, E). The appearance of BODIPY-C16 in intestinal,
hepatic, and pancreatic lipid droplets suggests that unlike the BODIPY
ﬂuorophore, this FA analog is transported and metabolized similarly
to native long chain FAs by zebraﬁsh larvae.
BODIPY-FL C12
Lipid droplets also appear in the digestive organs of larvae fed
BODIPY-FL C12 (Fig. 2). Similar to BODIPY-FL C16, apical and basolat-
eral differences in lipid analog accumulation are apparent in larval
enterocytes (Fig. 2A). Furthermore, analog feeding reveals a high de-
gree of subcellular detail in the intestine, enabling single enterocytes
to be clearly distinguished (Fig. 2A). More lipid droplets form in the
livers and pancreases of BODIPY-FL C12 fed larvae (Fig. 2B, C), consistent
with the faster absorption and metabolism of MCFAs. Accumulation of
the analog in the intestinal lumen suggests expedited transport of the
analog to the liver, drainage into hepatic ducts, and reentry into the in-
testinal lumen as bile (Fig. 2A). Studies done using the human parasite
Shistosomamasoni have also found that BODIPY-FL C12 localizes to intra-
cellular lipid droplets and membranes and is metabolized into neutral
lipids and phospholipids (Furlong et al., 1995).
BODIPY-FL C5
Larvae fed BODIPY-FL C5 reveal a high degree of cellular and sub-
cellular detail throughout their digestive systems (Fig. 3). Intestinal
enterocytes exhibit apical lipid droplets and basolateral analog accu-
mulation consistent with sites of lipoprotein secretion (Andre et al.,
2000) (Fig. 3A, B). Intestinal absorption of the analog decreases in
B C
A BODIPY-FL C12
Fig. 2. BODIPY-FL C12 is absorbed and transported in the digestive organs of zebraﬁsh larvae. A. The analog appears in the intestinal lumen as well as in lipid droplets in intestinal
enterocytes. Diffuse cellular accumulation of BODIPY-FL C12 is consistent with the analog's shorter chain length, decreased hydrophobicity, faster metabolism, and entry into more
subcellular compartments. B. BODIPY-FL C12 readily accumulates in the liver, visualizing large lipid droplets (ﬁlled arrowhead), hepatic ducts (arrow), and hepatocyte nuclei (empty
arrowhead). C. BODIPY-FL C12 accumulates in ﬂuorescent foci (arrowhead) in the exocrine pancreas. A Scale bars=10μm. (n=3; 6 larvae per feed.)
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composition (Wallace et al., 2005) and gene expression (Andre
et al., 2000) along the length of the intestine (data not shown). Differ-
ent intestinal cell types can be identiﬁed by their inability to absorb
the ﬂuorescent analogs, and are likely hormone-secreting enteroen-
docrine cells in the anterior intestine and mucosal cells in the poste-
rior intestine (Wallace et al., 2005).
In the liver, BODIPY-FL C5 reveals many subcellular details includ-
ing lipid droplets and hepatocyte nuclei (Fig. 3E), as well as the he-
patic ductal network (Fig. 3D and Supplementary Movie 1). Previous
work done in medaka ﬁsh has shown that larval exposure to BODIPY-
FL C5 in an aqueous bath is sufﬁcient to visualize the hepatobiliary net-
work, enabling analysis of ductal morphology, hepatobiliary transport,
and hepatotoxicity in vivo (Hardman et al., 2008). In our assay, analog
delivery via a high-fat diet enhances BODIPY FL uptake andmetabolism,
allowing more BODIPY-Fl C5 to be metabolized and incorporated into
subcellular structures.
In the exocrine pancreases of BODIPY-FL C5 fed larvae, zymogen
granules are observed in acinar cells, as well as pancreatic ducts
(Fig. 3C). The wealth of subcellular details observed in the digestive
organs of larvae fed BODIPY-FL C12 and C5 reﬂects the expedited me-
tabolism of medium chain FAs (MCFA) (reviewed in Papamandjaris
et al., 1998) and makes these two analogs particularly well suited
for use as vital dyes. In addition, the preference of acyl-CoA synthe-
tases for LCFA likely permits some MCFA to bypass TAG synthesis,
enter the blood, and travel directly to the liver via the portal vein
(Bach et al., 1996; Bloom et al., 1951).
BODIPY-FL C2
In contrast to the M- and LCFA analogs, BODIPY-FL C2 does not
enter lipid droplets in larval digestive organs and instead accumulatesin the intestinal lumen, intrahepatic biliary system, and pancreatic ducts
(Fig. 4). The diffuse cytoplasmicﬂuorescence observed in cells of BODIPY-
FL C2 fed larvae suggests the analog is excluded or actively exported from
cells. SCFAs are produced mainly by carbohydrate fermentation in the
large intestine, with acetate (C2:0), propionate (C3:0), and butyrate
(C4:0) being the main SCFAs generated (Cummings and Macfarlane,
1991). Although SCFAs are not typically utilized for TAG synthesis, they
can be used to make glycerol. We ﬁnd no imaging evidence of BODIPY-
FL C2 incorporation into TAG containing lipid droplets in fed zebraﬁsh lar-
vae, suggesting that this analog is not appreciably metabolized. Interest-
ingly, the addition of a 2-carbon length acyl chain to the BODIPY
ﬂuorophore drastically sways its accumulation pattern from hydro-
phobic lipid droplets to more hydrophilic environments. We hypothe-
size that the addition of a short acyl chain to BODIPY creates a more
amphipathic BODIPY-FL C2 analog that can self-associate, possibly
retarding its movement across cellular membranes.Egg yolk feeding enhances the metabolism of BODIPY-FL analogs
To determine whether zebraﬁsh larvae metabolize BODIPY-FL, we
analyzed lipid extracts from fed larvae using TLC. We ﬁrst determined
the effect of egg yolk feeding on larval uptake and metabolism of
BODIPY-FL by administering the analogs in the presence and absence
of egg yolk. TLC analysis reveals that BODIPY-FL analogs remain large-
ly unmetabolizedwhen administeredwithout of egg yolk (Fig. 5, lanes
1–6). Prominent bands in the BODIPY-FL C16 and BODIPY-FL C12 unfed
lanes correspond to ingested but unmetabolized analogs. The in-
creased ﬂuorescence intensity of the unmetabolized bands present in
the BODIPY-FL C16, BODIPY-FL C12, and BODIPY unfed lanes indicates
that the analog pool does not become diluted by yolk lipids in unfed lar-
vae (compare lanes 1, 2 and 5 with 7, 8 and 11).
CA
B
BODIPY-FL C5
*
D E
*
Fig. 3. BODIPY-FL C5 reveals signiﬁcant subcellular detailswithin larval digestive organs (6dpf). A. In enterocytes of the anterior intestine BODIPY-FL C5 appears in structures reminiscent
of lipid droplets. Lumenal accumulation of BODIPY-FL C5 in the intestine (arrow) is consistent with the expedited metabolism, transport and biliary concentration of medium chain fatty
acids. The analog also appears in a dorsal intestinal blood vessel (arrowhead) and in the liver (asterisk). B. Subcellular enterocytemorphology is visualized following a BODIPY-FL C5 feed.
Lipid droplets (ﬁlled arrowhead), a nucleus (empty arrowhead), apparent pericellular accumulation of the analog (arrows) and the intestinal lumen (asterisk) are indicated. C. BODIPY-FL
C5 visualizes subcellular details of acinar cells and pancreatic ducts in the larval exocrine pancreas. A single acinar cell (dashed box) containing a basal nucleus and apical zymogen gran-
ules, as well as pancreatic ducts (arrowhead) is indicated. D. BODIPY-FL C5 feeding illuminates the intrahepatobiliary ductal network. In the right liver lobe, a single long duct (arrow),
numerous interconnecting ducts and terminal ductules (arrowhead) are illuminated (see also Supplementary Movie-1). E. Subcellular details of larval hepatocytes are revealed by
BODIPY-FL C5 feeding. Lipid droplets (ﬁlled arrowhead), hepatocyte nuclei (empty arrowhead), and intrahepatic ducts (arrow) are indicated. A. is a composite of 2 separate confocal
images. Scale bars=10μm. (n=3; 6 larvae per feed.)
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lism of BODIPY-FL (Fig. 5, lanes 7–12). Fed larvae readily metabolize
long and medium chain BODIPY-FL when fed with egg yolk
(Fig. 5, lanes 7–9). Confocal imaging of yolk-fed and unfed larvae ad-
ministered BODIPY-FL C16 conﬁrms that the addition of egg yolk in-
creases analog uptake and lipid droplet formation in the intestine and
liver (Fig. S3).
Several factors likely enable the BODIPY-FL analogs to be metabo-
lized by zebraﬁsh larvae. In our assay, larvae are fed for 4–8 h, enabling
high amounts of analog to be continuously delivered. In addition,feeding is known to trigger metabolic responses (e.g., insulin secre-
tion, transcriptional upregulation of catabolic genes, and nutrient
transporter trafﬁcking to the plasma membrane) in an organism. By
feeding the BODIPY-FL analogs with egg yolk, we trigger a physiolog-
ical feeding response, which maximizes FA uptake and metabolism.
Furthermore, bile is critical for FA digestion and is pumped directly
into the intestinal lumen in response to food consumption. By enhanc-
ing bile production through the feeding of a high-fat meal, we
increase FA analog solubility and subsequent absorption by intestinal
enterocytes.
A BODIPY-FL C2
CB
Fig. 4. BODIPY-FL C2 does not participate appreciably in lipid metabolism. A. Unlike the longer chain length analogs, BODIPY-FL C2 ﬂuorescence appears primarily in the intestinal
lumen of larvae. B. In the liver BODIPY-FL C2 accumulates in the hepatic ducts (arrow) and diffusely in hepatocytes, whose nuclei are discernable (empty arrowhead). C. The ductal
network of the exocrine pancreas is also labeled (arrow). The gall bladder (ﬁlled arrowhead) is indicated in C. A. is a composite of 2 separate confocal images. Scale bars=10μm.
(n=3; 6 larvae per feed).
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TLC analysis conﬁrms that BODIPY-FL C16 is predominantly metab-
olized into triacylglycerol (TAG) (Fig. 5, lane 7; Fig. 6, lane 1), consis-
tent with its appearance in neutral lipid-containing lipid droplets and
presumed lipoproteins. Surprisingly, the analog is not appreciably
metabolized into phospholipids, as would be predicted given that
palmitate (C16:0) and stearate (C18:0) are the predominant saturat-
ed FAs in phospholipids (reviewed by Moore, 1982). Caco-2 cells
readily incorporate radiolabeled palmitic acid into phospholipids (van
Greevenbroek et al., 1995), though studies have shown that the rate
of phospholipid synthesis is less susceptible to diet, and remains rela-
tively constant, in contrast to triacylglyceride synthesis (Iritani et al.,
1976). Furthermore, fasting, as well as increased availability of palmi-
tate, stimulates triglyceride synthesis more so than phospholipid
synthesis, suggesting these lipogenic processes are regulated inde-
pendently (Iritani et al., 1976). While we do not know why zebraﬁsh
larvae preferentially metabolize BODIPY-FL C16 into neutral lipids, we
suspect native yolk-derived palmitate outcompetes BODIPY-FL C16.
The BODIPY ﬂuorophore is known to affect membrane partitioning
and metabolism of lipid analogs (Baumgart et al., 2007; Karsenty
et al., 2009), and likely causes the BODIPY-FL C16 analog to be metabo-
lized differently than native palmitic acid by zebraﬁsh larvae.
Zebraﬁsh larvae metabolize BODIPY-FL C12 and BODIPY-FL C5 into
complex lipids
Of the analogs tested, BODIPY-FL C12 and BODIPY-FL C5 are metabo-
lized to the greatest extent. Both analogs are synthesized intotriacylglycerides (Fig. 5, lanes 8, 9; Fig. 6, lanes 2, 3) and phosphatidly-
choline (Fig. 5, lanes 8, 9). Interestingly, unlike BODIPY-FL C16, the 12 car-
bon BODIPY-FL C12 analog is metabolized into phospholipids, suggesting
this MCFA analog is metabolized more like a LCFA due to its ﬂurophore-
lengthened acyl chain. Themultiple ﬂuorescent bands that appear at de-
creasing 2-carbon length increments below the unmetabolized bands
(Fig. 5, lanes 7–9) are likely the products of lipid catabolism, indicating
that the analogs can be burned as sources of cellular fuel. MCFAs
enter mitochondria independently of the carnitine transport system
(Friedman et al., 1990), thus BODIPY-FL C12 and BODIPY-FL C5 may be
short enough to directly enter the mitochondria to be oxidized. The
greater metabolic usage of BODIPY-FL C12 and BODIPY-FL C5 parallels
the high degree of subcellular detail apparent following larval feeding
and confocal imaging.
Zebraﬁsh larvae do not metabolize BODIPY-FL C2
Unlike the longer chain length analogs, zebraﬁsh larvae do not me-
tabolize BODIPY-FL C2, with little to no analog appearing in complex
lipids (Fig. 5, lane 11; Fig. 6, lane 4). This is consistent with BODIPY-FL
C2 fed larvae never exhibiting ﬂuorescent lipid droplets in their diges-
tive organs or lipid-accumulating tissues, concentrating the analog pri-
marily in the intestinal lumen and hepatic and pancreatic ducts (Fig. 4).
The differentialmetabolismof short chain FAs (SCFA) is likely due to the
preference ofmetabolic enzymes that process and transport FAs for lon-
ger chain length FAs (Hall et al., 2003; Hall et al., 2005; Stahl et al., 1999;
Steinberg et al., 1999). As expected, the BODIPY ﬂuorophore is not me-
tabolized by zebraﬁsh into complex lipids (Fig. 5 lanes 5, 11), despite its
accumulates in intestinal lipid drops.
B-C5
B-C2
B-C16
B-C12
7 Standards
C16     C12     C5     C2      B     NA C16    C12     C5    C2      B    NA
No Yolk  Yolk fed 
NFB
 B-PC-C12
11 121098 1
B-PC-C5
B; B-TAG-
C12
2 3 4 5 6
Fig. 5. Egg yolk feeding enhances the uptake and metabolism of BODIPY fatty acid analogs by zebraﬁsh larvae. Thin layer chromatography analysis of total larval lipids extracted
following analog feeds in the absence (lanes 1–5) and presence (lanes 7–11) of egg yolk. Lanes 6 and 12 are no analog (NA) unfed and yolk fed controls, respectively, and exhibit
faint naturally ﬂuorescent lipid bands (NFB). A polar solvent system was used to resolve ﬂuorescent phospholipids (bottom of plate), free analogs (middle), and neutral lipids (top
of plate). Abbreviations for ﬂuorescent lipid standards are as follows: BODIPY-Cholesteryl (B-CE-C12), BODIPY-Triacylglyceride (B-TAG-C12), BODIPY493/503 (B), BODIPY-C16 (B-C16),
and BODIPY-Phosphatidylcholine (B-PC-C12, B-PC-C5).
283J.D. Carten et al. / Developmental Biology 360 (2011) 276–285In summary, the TLC results conﬁrm that the uptake and transport
of the BODIPY-FL analogs observed in live zebraﬁsh larvae reﬂect
metabolic events speciﬁc to FAs (e.g., neutral and phospholipid syn-
thesis, β-oxidation). Furthermore, differences in the metabolites of
each chain length BODIPY-FL show that these analogs partition into
different metabolic pathways based on their chain length. C16    C12     C5      C2      B      NA   
 1        2        3        4        5       6 Standards
B-TG-C16
B-TG-C12
B
B-TG-C5
Fig. 6. Medium and long chain fatty acid BODIPY analogs are synthesized into triacyl-
glyceride. A second protonating solvent system was used to separate BODIPY493/503
(B) from BODIPY-Triacylglyceride (B-TAGs). Lipid extracts from larvae fed egg yolk
without analog (NA) appear in lane 6. (n=3 concurrent feeds).BODIPY-FL C5 feeding reveals a bile secretion defect in fat-free larvae
To demonstrate the utility of BODIPY-FL analogs to functionally
evaluate digestive mutants, we fed the previously identiﬁed mutant,
fat-free (ffr) (Farber et al., 2001). Larvae with a mutation at the ffr
locus exhibit reduced lipase activity and cholesterol absorption as
well as abnormal hepatic ducts and bile canaliculi (Ho et al., 2006),
suggesting a defect in bile secretion. To determine if bile secretion is
the basis for the ffr phenotype, we administered BODIPY-FL C5 lipo-
somes to these larvae. Fed ffr larvae exhibit apparent abnormal bile
accumulation in their hepatocytes (Fig. 7). Therefore, reduced lipase
activity and cholesterol absorption in ffr larvae likely results from a
bile secretion defect, due to the failure of canalicular and ductal net-
works to properly drain bile into the gall bladder. The cholestatic phe-
notype observed in ffr mutants is also consistent with the
ultrastructural defects observed in the Golgi of hepatocytes and bili-
ary cells of ffr larvae (5 dpf) (Ho et al., 2006). The Ffr protein is pre-
dicted to have a Dor-1 like domain characteristic of conserved
oligomeric golgi (COG) complex proteins that are essential for glyco-
sylation events and vesicular trafﬁcking. Thus, ffrmay be required for
proper Golgi-related vesicular trafﬁcking of bile transporters, suchthat in ffr mutants, bile transporters cannot be properly trafﬁcked to
the plasma membrane (Liu et al., 2010).
Conclusion
We have developed a feeding assay that allows FA metabolism to be
visualized in live larval zebraﬁsh. Yolk feeding enhances the uptake and
metabolism of these analogs, allowing a comparative analysis of FA me-
tabolism. Using this method we demonstrate that long, medium, and
short chain BODIPY-tagged FAs are differentially metabolized by zebra-
ﬁsh larvae, revealing FA metabolism to be conserved in these teleosts.
In addition, the distinct metabolism of each analog allows them to be
AC D
BODIPY-FL C5 B
wild-type fatfree
fatfree fatfree 
Fig. 7. Fat-free (ffr) larvae display abnormal bile accumulation upon BODIPY-FL C5 feeding. A. Wildtype siblings (controls) from a cross of ffr +/− larvae (6dpf) exhibit normal hepatic
accumulation of BODIPY-FL C5 in lipid droplets (ﬁlled arrowhead) and hepatic ducts (arrow). B. Hepatic ducts in ffr −/− larvae leak or abnormally accumulate BODIPY-FL C5,
consistent with the hepatobiliary structural malformations previously identiﬁed in these mutants. C. Analog labeling also reveals ffr −/− hepatocytes are unable to secrete
bile as indicated by the appearance of cholestatic livers. D. A higher magniﬁcation of C. reveals abnormal accumulation of bile in a single ffr−/− hepatocyte. Scale bars=10μm.
(n=3 feeds; 10 larvae per feed).
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function in vivo. BODIPY-FL C2 and -C5 are ideal for examining hepatic
and pancreatic ductal morphology, offering an expedited way to screen
for ductalmutants. BODIPY-FL C5 and BODIPY-FL C12 reveal a tremendous
amount of cellular detail in the intestine, liver, and pancreas and pro-
vide a way to live-image subcellular processes in these organs over
time and at various developmental stages. BODIPY-FL C16 accumulation
into lipid droplets and lipoproteins allows multiple fat storing organs
and tissues to be monitored simultaneously in vivo. In addition, these
analogs can serve as tools to assess the physiological effects of a speciﬁc
mutation or drug treatment, aswe have demonstrated using the ffrmu-
tant, andwill likely aid in the development of therapeutics formetabolic
disorders.
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line at doi:10.1016/j.ydbio.2011.09.010.Acknowledgments
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